# Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19

> **NCT04367714** · — · UNKNOWN · sponsor: **Region MidtJylland Denmark** · enrollment: 300 (estimated)

## Conditions studied

- COVID
- Terminal Renal Insufficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04367714
- **Lead sponsor:** Region MidtJylland Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-15
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-12-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04367714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04367714, "Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04367714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*